https://endocrinology-inhibito....r.com/index.php/obes
© 2020 S. Karger AG, Basel.INTRODUCTION Genetic aspects can modulate the introduction of associated comorbidities in obesity. It was shown that loss-of-function alternatives of this no-cost fatty acid receptor 4 (FFAR4) gene adversely affect obesity comorbidities such as insulin weight and fatty liver disease. OBJECTIVE To test the connections of metabolic facets in children with obesity with alternatives of the FFAR4 gene. METHODS We performed an association research
Like
Comment
Share
